US Stock MarketDetailed Quotes

MDXH MDxHealth

Watchlist
  • 1.645
  • +0.005+0.30%
Trading Nov 18 15:18 ET
81.42MMarket Cap-1075P/E (TTM)

MDxHealth Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
20.50%23.32M
32.33%22.16M
34.93%19.83M
89.43%70.19M
50.48%19.4M
73.48%19.35M
142.58%16.75M
140.75%14.7M
66.62%37.05M
114.39%12.89M
Operating revenue
20.50%23.32M
32.95%22.13M
34.93%19.83M
89.27%69.97M
49.14%19.17M
73.76%19.35M
141.83%16.65M
141.30%14.7M
68.51%36.97M
114.48%12.85M
Cost of revenue
33.03%9.04M
31.35%8.87M
29.84%7.77M
47.26%26.26M
18.70%6.73M
37.84%6.8M
69.98%6.76M
83.42%5.99M
52.76%17.84M
75.67%5.67M
Gross profit
13.72%14.28M
32.99%13.29M
38.42%12.06M
128.57%43.93M
75.40%12.67M
101.72%12.55M
241.07%9.99M
206.54%8.72M
81.93%19.22M
159.20%7.22M
Operating expense
19.01%20.37M
16.75%20.7M
7.08%18.67M
22.62%70.67M
10.21%18.39M
-5.72%17.11M
46.55%17.73M
62.99%17.43M
53.36%57.63M
63.43%16.69M
Selling and administrative expenses
13.25%16.35M
9.82%16.48M
7.84%15.39M
22.66%58.3M
19.85%14.59M
-9.01%14.44M
41.93%15M
60.06%14.27M
57.29%47.53M
71.62%12.17M
-Selling and marketing expense
17.21%10.62M
14.68%10.63M
10.21%10.03M
59.24%7.37M
-54.43%-20.07M
16.59%9.06M
70.88%9.27M
105.77%9.1M
52.99%4.63M
-36.08%-12.99M
-General and administrative expense
6.58%5.74M
1.95%5.84M
3.68%5.36M
18.72%50.94M
37.70%34.66M
-33.57%5.38M
11.39%5.73M
15.07%5.17M
57.77%42.9M
51.23%25.17M
Research and development costs
73.22%2.7M
73.42%2.9M
64.44%2.16M
15.99%6.38M
817.25%1.83M
-28.15%1.56M
-7.05%1.67M
-26.23%1.32M
-1.65%5.5M
-120.21%-255K
Depreciation amortization depletion
17.64%1.33M
0.72%1.12M
0.09%1.13M
31.51%6.12M
--2.75M
--1.13M
--1.12M
--1.12M
68.59%4.65M
----
-Depreciation and amortization
17.64%1.33M
0.72%1.12M
0.09%1.13M
31.51%6.12M
--2.75M
--1.13M
--1.12M
--1.12M
68.59%4.65M
----
Other operating expenses
8.33%-11K
450.00%203K
-101.24%-9K
-188.64%-127K
-779.13%-781K
-110.43%-12K
78.60%-58K
24,233.33%724K
95.53%-44K
112.71%115K
Operating profit
-33.57%-6.09M
4.20%-7.42M
24.24%-6.6M
30.39%-26.74M
39.57%-5.72M
61.77%-4.56M
15.57%-7.74M
-11.02%-8.72M
-42.19%-38.42M
-27.47%-9.46M
Net non-operating interest income expense
13.15%-4.76M
-360.76%-1.16M
36.26%-1.91M
-122.00%-5.81M
3,303.07%5.55M
-222.40%-5.48M
195.91%446K
-615.79%-2.99M
-39.93%-2.62M
129.91%163K
Non-operating interest income
-65.07%197K
----
----
770.40%1.09M
---482K
--564K
----
----
1,036.36%125K
----
Non-operating interest expense
-17.99%4.96M
810.26%1.39M
-36.26%1.91M
111.76%5.58M
-4,966.90%-7.35M
255.56%6.05M
-144.52%-195K
615.79%2.99M
40.59%2.64M
-126.95%-145K
Total other finance cost
----
----
----
1,131.78%1.32M
----
----
----
----
1,428.57%107K
----
Other net income (expense)
-250.32%-10.55M
-2,541.23%-3.01M
Gain on sale of security
----
----
----
1,061.21%1.35M
----
----
----
----
220.83%116K
----
Special income (charges)
----
----
----
-280.40%-11.9M
----
----
----
----
-17,272.22%-3.13M
----
-Less:Restructuring and merger&acquisition
----
----
----
471.88%11.9M
----
----
----
----
11,455.56%2.08M
----
-Less:Other special charges
----
----
----
----
----
----
----
----
--1.05M
----
Income before tax
-8.06%-10.86M
-8.49%-11.53M
27.31%-8.51M
2.15%-43.1M
12.92%-10.72M
26.31%-10.05M
-8.06%-10.63M
-41.58%-11.71M
-51.87%-44.04M
-52.31%-12.31M
Income tax
334K
0
0
1K
-99.22%1K
0
0
0
0
128K
Net income
-11.39%-11.19M
-8.49%-11.53M
27.31%-8.51M
2.14%-43.1M
13.81%-10.72M
25.60%-10.05M
-8.05%-10.63M
-41.58%-11.71M
-51.87%-44.04M
-53.90%-12.44M
Net income continuous Operations
-11.39%-11.19M
-8.49%-11.53M
27.31%-8.51M
2.14%-43.1M
13.81%-10.72M
25.60%-10.05M
-8.05%-10.63M
-41.58%-11.71M
-51.87%-44.04M
-53.90%-12.44M
Minority interest income
Net income attributable to the parent company
-11.39%-11.19M
-8.49%-11.53M
27.31%-8.51M
2.14%-43.1M
13.81%-10.72M
25.60%-10.05M
-8.05%-10.63M
-41.58%-11.71M
-51.87%-44.04M
-53.90%-12.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-11.39%-11.19M
-8.49%-11.53M
27.31%-8.51M
2.14%-43.1M
13.81%-10.72M
25.60%-10.05M
-8.05%-10.63M
-41.58%-11.71M
-51.87%-44.04M
-53.90%-12.44M
Basic earnings per share
-8.11%-0.4
-10.53%-0.42
41.51%-0.31
40.29%-1.66
50.00%-0.39
53.75%-0.37
45.71%-0.38
-6.00%-0.53
-16.81%-2.78
-34.48%-0.78
Diluted earnings per share
-8.11%-0.4
-10.53%-0.42
41.51%-0.31
40.29%-1.66
50.00%-0.39
53.75%-0.37
45.71%-0.38
-6.00%-0.53
-16.81%-2.78
-34.48%-0.78
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Total revenue 20.50%23.32M 32.33%22.16M 34.93%19.83M 89.43%70.19M 50.48%19.4M 73.48%19.35M 142.58%16.75M 140.75%14.7M 66.62%37.05M 114.39%12.89M
Operating revenue 20.50%23.32M 32.95%22.13M 34.93%19.83M 89.27%69.97M 49.14%19.17M 73.76%19.35M 141.83%16.65M 141.30%14.7M 68.51%36.97M 114.48%12.85M
Cost of revenue 33.03%9.04M 31.35%8.87M 29.84%7.77M 47.26%26.26M 18.70%6.73M 37.84%6.8M 69.98%6.76M 83.42%5.99M 52.76%17.84M 75.67%5.67M
Gross profit 13.72%14.28M 32.99%13.29M 38.42%12.06M 128.57%43.93M 75.40%12.67M 101.72%12.55M 241.07%9.99M 206.54%8.72M 81.93%19.22M 159.20%7.22M
Operating expense 19.01%20.37M 16.75%20.7M 7.08%18.67M 22.62%70.67M 10.21%18.39M -5.72%17.11M 46.55%17.73M 62.99%17.43M 53.36%57.63M 63.43%16.69M
Selling and administrative expenses 13.25%16.35M 9.82%16.48M 7.84%15.39M 22.66%58.3M 19.85%14.59M -9.01%14.44M 41.93%15M 60.06%14.27M 57.29%47.53M 71.62%12.17M
-Selling and marketing expense 17.21%10.62M 14.68%10.63M 10.21%10.03M 59.24%7.37M -54.43%-20.07M 16.59%9.06M 70.88%9.27M 105.77%9.1M 52.99%4.63M -36.08%-12.99M
-General and administrative expense 6.58%5.74M 1.95%5.84M 3.68%5.36M 18.72%50.94M 37.70%34.66M -33.57%5.38M 11.39%5.73M 15.07%5.17M 57.77%42.9M 51.23%25.17M
Research and development costs 73.22%2.7M 73.42%2.9M 64.44%2.16M 15.99%6.38M 817.25%1.83M -28.15%1.56M -7.05%1.67M -26.23%1.32M -1.65%5.5M -120.21%-255K
Depreciation amortization depletion 17.64%1.33M 0.72%1.12M 0.09%1.13M 31.51%6.12M --2.75M --1.13M --1.12M --1.12M 68.59%4.65M ----
-Depreciation and amortization 17.64%1.33M 0.72%1.12M 0.09%1.13M 31.51%6.12M --2.75M --1.13M --1.12M --1.12M 68.59%4.65M ----
Other operating expenses 8.33%-11K 450.00%203K -101.24%-9K -188.64%-127K -779.13%-781K -110.43%-12K 78.60%-58K 24,233.33%724K 95.53%-44K 112.71%115K
Operating profit -33.57%-6.09M 4.20%-7.42M 24.24%-6.6M 30.39%-26.74M 39.57%-5.72M 61.77%-4.56M 15.57%-7.74M -11.02%-8.72M -42.19%-38.42M -27.47%-9.46M
Net non-operating interest income expense 13.15%-4.76M -360.76%-1.16M 36.26%-1.91M -122.00%-5.81M 3,303.07%5.55M -222.40%-5.48M 195.91%446K -615.79%-2.99M -39.93%-2.62M 129.91%163K
Non-operating interest income -65.07%197K ---- ---- 770.40%1.09M ---482K --564K ---- ---- 1,036.36%125K ----
Non-operating interest expense -17.99%4.96M 810.26%1.39M -36.26%1.91M 111.76%5.58M -4,966.90%-7.35M 255.56%6.05M -144.52%-195K 615.79%2.99M 40.59%2.64M -126.95%-145K
Total other finance cost ---- ---- ---- 1,131.78%1.32M ---- ---- ---- ---- 1,428.57%107K ----
Other net income (expense) -250.32%-10.55M -2,541.23%-3.01M
Gain on sale of security ---- ---- ---- 1,061.21%1.35M ---- ---- ---- ---- 220.83%116K ----
Special income (charges) ---- ---- ---- -280.40%-11.9M ---- ---- ---- ---- -17,272.22%-3.13M ----
-Less:Restructuring and merger&acquisition ---- ---- ---- 471.88%11.9M ---- ---- ---- ---- 11,455.56%2.08M ----
-Less:Other special charges ---- ---- ---- ---- ---- ---- ---- ---- --1.05M ----
Income before tax -8.06%-10.86M -8.49%-11.53M 27.31%-8.51M 2.15%-43.1M 12.92%-10.72M 26.31%-10.05M -8.06%-10.63M -41.58%-11.71M -51.87%-44.04M -52.31%-12.31M
Income tax 334K 0 0 1K -99.22%1K 0 0 0 0 128K
Net income -11.39%-11.19M -8.49%-11.53M 27.31%-8.51M 2.14%-43.1M 13.81%-10.72M 25.60%-10.05M -8.05%-10.63M -41.58%-11.71M -51.87%-44.04M -53.90%-12.44M
Net income continuous Operations -11.39%-11.19M -8.49%-11.53M 27.31%-8.51M 2.14%-43.1M 13.81%-10.72M 25.60%-10.05M -8.05%-10.63M -41.58%-11.71M -51.87%-44.04M -53.90%-12.44M
Minority interest income
Net income attributable to the parent company -11.39%-11.19M -8.49%-11.53M 27.31%-8.51M 2.14%-43.1M 13.81%-10.72M 25.60%-10.05M -8.05%-10.63M -41.58%-11.71M -51.87%-44.04M -53.90%-12.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -11.39%-11.19M -8.49%-11.53M 27.31%-8.51M 2.14%-43.1M 13.81%-10.72M 25.60%-10.05M -8.05%-10.63M -41.58%-11.71M -51.87%-44.04M -53.90%-12.44M
Basic earnings per share -8.11%-0.4 -10.53%-0.42 41.51%-0.31 40.29%-1.66 50.00%-0.39 53.75%-0.37 45.71%-0.38 -6.00%-0.53 -16.81%-2.78 -34.48%-0.78
Diluted earnings per share -8.11%-0.4 -10.53%-0.42 41.51%-0.31 40.29%-1.66 50.00%-0.39 53.75%-0.37 45.71%-0.38 -6.00%-0.53 -16.81%-2.78 -34.48%-0.78
Dividend per share
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion with Explanatory Notes -- -- -- -- Unqualified Opinion --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data